why choose us

First received: June 07, 2023

Clinical Trial: Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Lung Cancer After Immunotherapy Resistance

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer Patients

Study Type: INTERVENTIONAL


Official Title: A Clinical Study on Low-dose Radiotherapy Combined With Conventional Fractionated Radiotherapy in Non Small Cell Lung Cancer After Immunotherapy Resistance

Brief Summary: Pre-clinical and clinical studies have shown that low-dose radiation therapy has good immune regulatory effects, activates different anti-tumor immune pathways, and regulates tumor stroma to better promote T cell infiltration.Conventional fractionated radiotherapy increases antigen release and presentation, and stimulates immune cells.In theory, the combination of the two can reverse immune resistance.Our study aims to clarify the efficacy and safety of low-dose radiotherapy combined with conventional fractionated…

Read more